CMN 571 Unit 4 Test – 2026/2027
Edition – 50 Complete Questions &
Correct Answers
Questions with Step-by-Step Answers | 100% Verified | A+ Graded Review
OVERVIEW:
CMN 571 Unit 4 Test – 2026/2027 covers adult cardiovascular health promotion,
hypertension diagnosis and management, dyslipidemia and hypertriglyceridemia
treatment, metabolic syndrome criteria, diabetes screening and A1c targets,
ASCVD risk assessment, Adult Smiles for Life oral systemic health, lifestyle
interventions, tobacco cessation, statin therapy, and prevention strategies
emphasizing evidence-based guidelines including DASH diet, medication safety,
and patient education principles today.
Answers are in bold Green, with rationales after.
1. A 45-year-old male with LDL at goal on atorvastatin 20mg but triglycerides remain
at 245 mg/dL. Fasting. No pancreatitis history. What is the next best step per
ACC/AHA?
A. Add prescription icosapent ethyl if ASCVD risk factors present and optimize
lifestyle
B. Add fenofibrate immediately
C. Stop statin and start niacin
D. Increase atorvastatin to 80mg to lower TG
Rationale: When TG 135-499 mg/dL and LDL at goal on statin with increased ASCVD
risk or established ASCVD, icosapent ethyl 2g BID can be considered. Fibrates primarily
for TG >500 to prevent pancreatitis. Lifestyle optimization is first.
,2. According to ACC/AHA 2017 HTN guidelines, what is the threshold for Stage 1
Hypertension?
A. 120-129/<80 mmHg
B. 130-139 systolic or 80-89 diastolic
C. 140-159 systolic or 90-99 diastolic
D. ≥160 systolic or ≥100 diastolic
Rationale: Stage 1 HTN is defined as 130-139 mmHg systolic or 80-89 diastolic.
Elevated is 120-129/<80. Stage 2 is ≥140 or ≥90.
3. Which lab pattern best defines metabolic syndrome per ATP III criteria?
A. BMI >30 plus LDL >160 and A1c >6.5%
B. 2 of 3: hypertension, obesity, hyperglycemia
C. 3 of 5: waist circumference, TG ≥150, HDL low, BP ≥130/85, fasting glucose ≥100
D. Waist circumference alone >40 inches in men
Rationale: ATP III requires 3 of 5 criteria: abdominal obesity, TG ≥150, low HDL (<40
men, <50 women), BP ≥130/85, fasting glucose ≥100 mg/dL.
4. A 52-year-old woman with diabetes and 10-year ASCVD risk 15%. LDL 92 mg/dL on
high-intensity statin. Which additional agent is indicated for secondary prevention of
ASCVD?
A. Ezetimibe only if LDL >100
B. Add PCSK9 inhibitor routinely
C. No additional agent if LDL <100 on statin
D. Add icosapent ethyl for LDL 92
Rationale: For high-risk primary prevention with diabetes and LDL at goal <100 on
maximally tolerated statin, no additional LDL-lowering agent is automatically required
unless LDL remains ≥70 with additional risk enhancers. Icosapent ethyl is for TG
elevation, PCSK9 for very high risk with LDL ≥70 despite statin+ezetimibe.
5. First-line pharmacologic treatment for uncomplicated hypertension in a non-Black
adult without compelling indications is:
, A. Beta-blocker
B. Loop diuretic
C. Thiazide diuretic, ACE inhibitor, ARB, or dihydropyridine CCB
D. Central alpha agonist
Rationale: Thiazide, ACEi, ARB, or DHP CCB are first-line per ACC/AHA for general non-
Black population. Beta-blockers not first-line unless compelling indication like HF,
post-MI.
6. A patient on lisinopril develops dry cough. No angioedema. Best alternative?
A. Switch to losartan
B. Continue lisinopril and add dextromethorphan
C. Switch to amlodipine only
D. Switch to hydralazine
Rationale: ACE-induced cough due to bradykinin accumulation. ARB does not increase
bradykinin significantly and is preferred replacement if no angioedema history. If
angioedema history, avoid both ACE and ARB initially.
7. USPSTF screening recommendation for abdominal aortic aneurysm (AAA):
A. One-time ultrasound in men 65-75 who ever smoked
B. Annual CT in all men >60
C. One-time ultrasound in all women 65-75
D. No screening recommended
Rationale: USPSTF B recommendation: one-time screening for AAA with
ultrasonography in men aged 65-75 who have ever smoked.
8. Which statin intensity is recommended for a 50-year-old with diabetes and no
ASCVD with 10-year ASCVD risk 12%?
A. No statin
B. Low-intensity
C. High-intensity
D. Moderate-intensity
Edition – 50 Complete Questions &
Correct Answers
Questions with Step-by-Step Answers | 100% Verified | A+ Graded Review
OVERVIEW:
CMN 571 Unit 4 Test – 2026/2027 covers adult cardiovascular health promotion,
hypertension diagnosis and management, dyslipidemia and hypertriglyceridemia
treatment, metabolic syndrome criteria, diabetes screening and A1c targets,
ASCVD risk assessment, Adult Smiles for Life oral systemic health, lifestyle
interventions, tobacco cessation, statin therapy, and prevention strategies
emphasizing evidence-based guidelines including DASH diet, medication safety,
and patient education principles today.
Answers are in bold Green, with rationales after.
1. A 45-year-old male with LDL at goal on atorvastatin 20mg but triglycerides remain
at 245 mg/dL. Fasting. No pancreatitis history. What is the next best step per
ACC/AHA?
A. Add prescription icosapent ethyl if ASCVD risk factors present and optimize
lifestyle
B. Add fenofibrate immediately
C. Stop statin and start niacin
D. Increase atorvastatin to 80mg to lower TG
Rationale: When TG 135-499 mg/dL and LDL at goal on statin with increased ASCVD
risk or established ASCVD, icosapent ethyl 2g BID can be considered. Fibrates primarily
for TG >500 to prevent pancreatitis. Lifestyle optimization is first.
,2. According to ACC/AHA 2017 HTN guidelines, what is the threshold for Stage 1
Hypertension?
A. 120-129/<80 mmHg
B. 130-139 systolic or 80-89 diastolic
C. 140-159 systolic or 90-99 diastolic
D. ≥160 systolic or ≥100 diastolic
Rationale: Stage 1 HTN is defined as 130-139 mmHg systolic or 80-89 diastolic.
Elevated is 120-129/<80. Stage 2 is ≥140 or ≥90.
3. Which lab pattern best defines metabolic syndrome per ATP III criteria?
A. BMI >30 plus LDL >160 and A1c >6.5%
B. 2 of 3: hypertension, obesity, hyperglycemia
C. 3 of 5: waist circumference, TG ≥150, HDL low, BP ≥130/85, fasting glucose ≥100
D. Waist circumference alone >40 inches in men
Rationale: ATP III requires 3 of 5 criteria: abdominal obesity, TG ≥150, low HDL (<40
men, <50 women), BP ≥130/85, fasting glucose ≥100 mg/dL.
4. A 52-year-old woman with diabetes and 10-year ASCVD risk 15%. LDL 92 mg/dL on
high-intensity statin. Which additional agent is indicated for secondary prevention of
ASCVD?
A. Ezetimibe only if LDL >100
B. Add PCSK9 inhibitor routinely
C. No additional agent if LDL <100 on statin
D. Add icosapent ethyl for LDL 92
Rationale: For high-risk primary prevention with diabetes and LDL at goal <100 on
maximally tolerated statin, no additional LDL-lowering agent is automatically required
unless LDL remains ≥70 with additional risk enhancers. Icosapent ethyl is for TG
elevation, PCSK9 for very high risk with LDL ≥70 despite statin+ezetimibe.
5. First-line pharmacologic treatment for uncomplicated hypertension in a non-Black
adult without compelling indications is:
, A. Beta-blocker
B. Loop diuretic
C. Thiazide diuretic, ACE inhibitor, ARB, or dihydropyridine CCB
D. Central alpha agonist
Rationale: Thiazide, ACEi, ARB, or DHP CCB are first-line per ACC/AHA for general non-
Black population. Beta-blockers not first-line unless compelling indication like HF,
post-MI.
6. A patient on lisinopril develops dry cough. No angioedema. Best alternative?
A. Switch to losartan
B. Continue lisinopril and add dextromethorphan
C. Switch to amlodipine only
D. Switch to hydralazine
Rationale: ACE-induced cough due to bradykinin accumulation. ARB does not increase
bradykinin significantly and is preferred replacement if no angioedema history. If
angioedema history, avoid both ACE and ARB initially.
7. USPSTF screening recommendation for abdominal aortic aneurysm (AAA):
A. One-time ultrasound in men 65-75 who ever smoked
B. Annual CT in all men >60
C. One-time ultrasound in all women 65-75
D. No screening recommended
Rationale: USPSTF B recommendation: one-time screening for AAA with
ultrasonography in men aged 65-75 who have ever smoked.
8. Which statin intensity is recommended for a 50-year-old with diabetes and no
ASCVD with 10-year ASCVD risk 12%?
A. No statin
B. Low-intensity
C. High-intensity
D. Moderate-intensity
